Breast Cancer
News
Bevacizumab Boosts Treatment Responses in Early Breast Cancer
Major Finding: Adding bevacizumab to neoadjuvant chemotherapy increased the rate of pathological complete response from 28.2% to 34.5% in one...
News
Trastuzumab Bests Lapatinib for HER2 Breast Cancer
Major Finding: In the GeparQuinto trial, 30% of 307 HER2-positive patients treated with trastuzumab had a pathological complete response, compared...
News
The Top 10 Stories on OncologyReport.com in 2011
News
Safety of Skin-Sparing Mastectomy Confirmed Short-Term
Major Finding: Of 412 patients who underwent therapeutic total skin-sparing mastectomies and immediate reconstruction, four patients (1%)...